The program is administered by the Health Resources and Services Administration (HRSA) with oversight carried out by its Office of Pharmacy Affairs (OPA). Under the program, drug manufacturers are required to provide outpatient drugs to these eligible health care organizations at significantly reduced prices. Per HRSA, the 3. 40. B Program . Department of Health and Human Services, is the primary federal agency charged with improving access to health care services for people who are uninsured, isolated or medically vulnerable. The Office of Pharmacy Affairs (OPA) is the arm of HRSA that administers the 3. B drug discount program. The 3. 40. B Prime Vendor Program (PVP) is managed by Apexus through a contract with HRSA.
Apexus is responsible for securing sub- ceiling discounts on outpatient drug purchases and discounts on other pharmacy- related products and services for participating public hospitals, community health centers, and other safety net health care providers. B Solutions can assist you in taking advantage of the Prime Vendor Program.
What is 3. 40. B and How Does it Work? The 3. 40. B Drug Pricing Program was created in 1. Federally Qualified Health Centers. The program requires drug manufacturers to provide outpatient drugs to these eligible health care organizations at significantly reduced prices. B was designed to promote: access to affordable medicationsefficient business practicesoutcome- driven pharmacy servicesquality assurance.
340B Drug Discount Program. The 340B program, passed by Congress in November 1992 and signed into law as part of the Veterans Health Care Act by George H. Bush, requires pharmaceutical manufacturers provide front-end. 340B University Page 1 Glossary of 340B Terms Apexus Answers Call Center . Congress created the 340B Drug Discount Program in 1992 to reduce outpatient prescription drug costs for safety net health care providers, enabling them to stretch scarce resources as far as possible. The 340B Drug Discount Program is a U.S federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced.
The end goal of the federal program is to enable covered entities “to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”.
What is the 340B program?